科研成果详情

题名PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor
作者
发表日期2022
发表期刊THERANOSTICS   影响因子和分区
语种英语
原始文献类型Article
关键词glioblastoma cell reprogramming PTBP1 proliferation neural differentiation
其他关键词CENTRAL-NERVOUS-SYSTEM ; PROTEIN-KINASE ; GROWTH ; RHO ; METABOLISM ; EXPRESSION ; CONVERSION ; APOPTOSIS ; DISEASE ; TUMORS
摘要Rationale: Cell reprogramming technology is utilized to prevent cancer progression by transforming cells into terminally differentiated, non-proliferating states. Polypyrimidine tract binding protein 1 (PTBP1) is an RNA binding protein required for the growth of neurons and may directly transform multiple normal human cells into functioning neurons in vitro and in vivo when expressed at low levels. As a result, we identified it as a key to inhibiting cancer cell proliferation by boosting glioblastoma cell neural differentiation. Methods: Immunocytofluorescence (ICF) targeting TUJ1, MAP2, KI67, and EdU were utilized to evaluate glioblastoma cell reprogramming under PTBP1 knockdown or other conditions. PTBP1 and other target genes were detected using Western blotting and qRT-PCR. Activating protein phosphatase 2A (PP2A) and RhoA were detected using specific kits. CCK8 assays were employed to detect cell viability. Bioluminescence, immunohistofluorescence (IHF), and Kaplan-Meier survival analyses were utilized to demonstrate the in vivo reprogramming efficiency of PTBP1 knockdown in U87 murine glioblastoma model. In this study, RNA-seq technology was used to examine the intrinsic pathway. Results: The expression of TUJ1 and MAP2 neural markers, as well as the absence of KI67 and EdU proliferative markers in U251, U87, and KNS89 cells, indicated that glioblastoma cell reprogramming was successful. In vivo, U87 growth generated xenografts was substantially shrank due to PTBP1 knockdown induced neural differentiation, and these tumor-bearing mice had a prolonged survival time. Following RNA-seq, ten potential downstream genes were eliminated. Lentiviral interference and inhibitors blocking tests demonstrated that UNC5B receptor and its downstream signaling were essential in the neural differentiation process mediated by PTBP1 knockdown in glioblastoma cells. Conclusions: Our results indicate that PTBP1 knockdown promotes neural differentiation of glioblastoma cells via UNC5B receptor, consequently suppressing cancer cell proliferation in vitro and in vivo, providing a promising and feasible approach for glioblastoma treatment.
资助项目National Natural Science Foundation of China [82103216, 81820108011]; Zhejiang Provincial Natural Science Foundation of China [LQ20H090005]
出版者IVYSPRING INT PUBL
出版地LAKE HAVEN
ISSN1838-7640
卷号12期号:8页码:3847-3861
DOI10.7150/thno.71100
页数15
WOS类目Medicine, Research & Experimental
WOS研究方向Research & Experimental Medicine
WOS记录号WOS:000803991200004
收录类别SCIE ; SCOPUS ; PUBMED
URL查看原文
Pubmed记录号35664063
Scopus记录号2-s2.0-85131341987
通讯作者地址[Zhuge, Qichuan]Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research,The First Affiliated Hospital of Wenzhou Medical University,Zhejiang,Wenzhou,325000,China ; [Yang, Jianjing]Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research,The First Affiliated Hospital of Wenzhou Medical University,Zhejiang,Wenzhou,325000,China
scopus学科分类Medicine (miscellaneous);Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
引用统计
被引频次[WOS]:0   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/148340
专题第一临床医学院(信息与工程学院)、附属第一医院_老化与神经疾病重点实验室
附属第一医院_神经外科
通讯作者Zhuge, Qichuan; Yang, Jianjing
作者单位
1.Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,325000,China;
2.Department of Neurosurgery,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,325000,China;
3.Zhejiang Provincial Key Laboratory of Interventional Pulmonology,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,325000,China
第一作者单位附属第一医院;  第一临床医学院(信息与工程学院)、附属第一医院
通讯作者单位附属第一医院;  第一临床医学院(信息与工程学院)、附属第一医院
第一作者的第一单位附属第一医院
推荐引用方式
GB/T 7714
Wang, Kankai,Pan, Sishi,Zhao, Peiqi,et al. PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor[J]. THERANOSTICS,2022,12(8):3847-3861.
APA Wang, Kankai., Pan, Sishi., Zhao, Peiqi., Liu, Li., Chen, Zhen., ... & Yang, Jianjing. (2022). PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor. THERANOSTICS, 12(8), 3847-3861.
MLA Wang, Kankai,et al."PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor".THERANOSTICS 12.8(2022):3847-3861.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Wang, Kankai]的文章
[Pan, Sishi]的文章
[Zhao, Peiqi]的文章
百度学术
百度学术中相似的文章
[Wang, Kankai]的文章
[Pan, Sishi]的文章
[Zhao, Peiqi]的文章
必应学术
必应学术中相似的文章
[Wang, Kankai]的文章
[Pan, Sishi]的文章
[Zhao, Peiqi]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。